216 related articles for article (PubMed ID: 6378045)
1. Lorcainide in the prophylaxis of ventricular arrhythmias in acute myocardial infarction.
Leinonen H; Heikkilä J; Sundberg S; Gordin A
Ann Clin Res; 1984; 16(1):18-22. PubMed ID: 6378045
[TBL] [Abstract][Full Text] [Related]
2. Antiarrhythmic effect of lorcainide during chronic treatment.
Meinertz T; Kasper W; Kersting F; Bechtold H; Just H; Jähnchen E
Arzneimittelforschung; 1980; 30(9):1593-5. PubMed ID: 7193031
[TBL] [Abstract][Full Text] [Related]
3. Comparison of the antiarrhythmic activity of mexiletine and lorcainide on ventricular arrhythmias.
Meinertz T; Kasper W; Stengel E; Waldecker B; Löllgen H; Jähnchen E; Bechtold H; Just J
Z Kardiol; 1982 Jan; 71(1):35-8. PubMed ID: 7039160
[TBL] [Abstract][Full Text] [Related]
4. Comparison of intravenous lorcainide with lidocaine for acute therapy of complex ventricular arrhythmias: results of a randomized study with crossover option.
Anderson JL; Anastasiou-Nana M; Lutz JR; Writer SL
J Am Coll Cardiol; 1985 Feb; 5(2 Pt 1):333-41. PubMed ID: 3881497
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of lorcainide, a new anti-arrhythmic agent.
Lloyd EA; Workman LJ; Commerford PJ; Mabin TA
S Afr Med J; 1981 Dec; 60(24):929-31. PubMed ID: 7302777
[TBL] [Abstract][Full Text] [Related]
6. Acute effects of antiarrhythmic drugs on stable ventricular premature beats. Controlled comparison of lorcainide and lidocaine.
Schmidt G; Klein G; Wirtzfeld A
Eur J Clin Pharmacol; 1985; 27(6):633-6. PubMed ID: 2580712
[TBL] [Abstract][Full Text] [Related]
7. Intravenous lorcainide for symptomatic ventricular tachyarrhythmias: comparison with lidocaine and oral lorcainide.
Hohnloser SH; Podrid PJ; Lown B
Am Heart J; 1988 Apr; 115(4):824-30. PubMed ID: 3354411
[TBL] [Abstract][Full Text] [Related]
8. Haemodynamic reactions after intravenous injection of lorcainide hydrochloride in acute myocardial infarction.
Shita A; Bernard R; Mostinckx R; Debacker M
Eur J Cardiol; 1981; 12(5):237-42. PubMed ID: 7250167
[TBL] [Abstract][Full Text] [Related]
9. [Hemodynamic repercussions and clinical tolerance of 6 class I anti-arrhythmia agents in acute myocardial infarction].
Bernard R; Renard M; Shita A; de Hemptinne J; Gillet JM; Lewinson H; Liebens I; Waterschoot P
Ann Cardiol Angeiol (Paris); 1986 Apr; 35(4):195-8. PubMed ID: 3090925
[TBL] [Abstract][Full Text] [Related]
10. [Therapeutic and preventive effect of oral lidocaine in extrasystole].
Nikolov G; Zlatereva N; Shabani R; Tashkova N
Vutr Boles; 1982; 21(6):32-5. PubMed ID: 6187132
[TBL] [Abstract][Full Text] [Related]
11. Lorcainide. A comparative trial with quinidine gluconate in patients with previously untreated ventricular arrhythmias.
Falk RH; O'Brien JL
Chest; 1984 Oct; 86(4):537-40. PubMed ID: 6383741
[TBL] [Abstract][Full Text] [Related]
12. [Lorcainide in stable ventricular extrasystole. A double-blind study with 48-hour continuous ECG recording].
Buss J; Stegaru B; Geiger S; Gores D; Heene DL
Dtsch Med Wochenschr; 1984 Nov; 109(48):1829-32. PubMed ID: 6209080
[TBL] [Abstract][Full Text] [Related]
13. Lorcainide. A preliminary review of its pharmacodynamic properties and therapeutic efficacy.
Eiriksson Ce; Brogden RN
Drugs; 1984 Apr; 27(4):279-300. PubMed ID: 6373222
[TBL] [Abstract][Full Text] [Related]
14. Comparison of the electrophysiologic effects of intravenous and oral lorcainide in patients with recurrent ventricular tachycardia.
Echt DS; Mitchell LB; Kates RE; Winkle RA
Circulation; 1983 Aug; 68(2):392-9. PubMed ID: 6861314
[TBL] [Abstract][Full Text] [Related]
15. Intravenous lorcainide versus lidocaine in the treatment of frequent and complex ventricular arrhythmias.
Blevins RD; Kerin NZ; Mathias P; Pesola D; Faitel K; Jarandilla R; Garfinkel C; Rubenfire M
Am Heart J; 1986 Mar; 111(3):447-51. PubMed ID: 3953351
[TBL] [Abstract][Full Text] [Related]
16. Long term lorcainide therapy guided by electrophysiology studies.
Somberg J; Butler B; Flowers D; Tepper D; Torres V
Acta Cardiol; 1985; 40(6):621-36. PubMed ID: 3879419
[TBL] [Abstract][Full Text] [Related]
17. Disposition and antiarrhythmic effect of lorcainide.
Klotz U; Müller-Seydlitz P; Heimburg P
Int J Clin Pharmacol Biopharm; 1979 Apr; 17(4):152-8. PubMed ID: 376458
[TBL] [Abstract][Full Text] [Related]
18. Resistant ventricular arrhythmias treated with lorcainide, a new antiarrhythmic drug.
Somani P; di Giorgi S
Chest; 1980 Oct; 78(4):658-60. PubMed ID: 7418495
[TBL] [Abstract][Full Text] [Related]
19. Efficacy and tolerance of intravenous lorcainide in patients with normal and impaired intraventricular conduction.
Stroobandt R; Kesteloot H
Acta Cardiol; 1985; 40(6):637-48. PubMed ID: 3879420
[TBL] [Abstract][Full Text] [Related]
20. [Effects of lorcainide, a new antiarrhythmic agent, on experimental cardiac arrhythmias].
Fukuda H; Goto M; Kondo M; Uchigasaki T; Sekino Y
Nihon Yakurigaku Zasshi; 1983 Feb; 81(2):115-26. PubMed ID: 6852683
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
